# Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas

> **NCT01189864** · — · TERMINATED · sponsor: **Cxlusa** · enrollment: 3493 (actual)

## Conditions studied

- Keratoconus
- Ectasia
- Degeneration

## Interventions

- **DRUG:** Ciprofloxicin or Vigamox or other.
- **DRUG:** Nonsteroidal (Acular, Acuvail, Voltaren Xibrom, etc)
- **DRUG:** Steroid (FML, Pred Forte, Flarex, etc.)

## Key facts

- **NCT ID:** NCT01189864
- **Lead sponsor:** Cxlusa
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02-01
- **Primary completion:** 2017-02-03
- **Final completion:** 2017-02-03
- **Target enrollment:** 3493 (ACTUAL)
- **Why stopped:** Terminated to initiate FDA IND-cleared study protocol
- **Last updated:** 2018-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01189864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01189864, "Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01189864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*